The Incidence and Prevalence of Thyroid Disease Do Not Differ in the Multiple Sclerosis and General Populations: A Validation Study Using Administrative Data

Autoimmune disease after alemtuzumab treatment for multiple sclerosis in a multicenter cohort

(2011) M. Cossburn et al.   NEUROLOGY

Multiple sclerosis and other immunologic diseases

(2010) S. Seyfert et al.   ACTA NEUROLOGICA SCANDINAVICA

Comparing administrative and survey data for ascertaining cases of irritable bowel syndrome: a population-based investigation

(2010) Lisa M Lix et al.   BMC HEALTH SERVICES RESEARCH

Comorbidities amongst patients with multiple sclerosis: a population-based controlled study

(2010) J.-H. Kang et al.   EUROPEAN JOURNAL OF NEUROLOGY

Emerging effects of comorbidities on multiple sclerosis

(2010) Ruth Ann Marrie et al.   LANCET NEUROLOGY

Validation of a Self-Report Comorbidity Questionnaire for Multiple Sclerosis

(2010) Myles Horton et al.   NEUROEPIDEMIOLOGY

The rising prevalence and changing age distribution of multiple sclerosis in Manitoba

(2010) R. A. Marrie et al.   NEUROLOGY

Impact of Comorbidities on Stroke Rehabilitation Outcomes: Does the Method Matter?

(2008) Dan R. Berlowitz et al.   ARCHIVES OF PHYSICAL MEDICINE AND REHABILITATION

Alemtuzumab vs. Interferon Beta-1a in Early Multiple Sclerosis

(2008)   NEW ENGLAND JOURNAL OF MEDICINE

Manitoba and Saskatchewan administrative health care utilization databases are used differently to answer epidemiologic research questions

(2007) Andrea C. Tricco et al.   JOURNAL OF CLINICAL EPIDEMIOLOGY